Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

GEN3013 Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03625037
Recruitment Status : Recruiting
First Posted : August 10, 2018
Last Update Posted : February 15, 2021
Sponsor:
Collaborator:
AbbVie
Information provided by (Responsible Party):
Genmab

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 30, 2022
Estimated Study Completion Date : December 30, 2025